A. Garcı́a-Merino

1.4k total citations
18 papers, 480 citations indexed

About

A. Garcı́a-Merino is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, A. Garcı́a-Merino has authored 18 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Immunology. Recurrent topics in A. Garcı́a-Merino's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Cannabis and Cannabinoid Research (3 papers). A. Garcı́a-Merino is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (5 papers) and Cannabis and Cannabinoid Research (3 papers). A. Garcı́a-Merino collaborates with scholars based in Spain, United States and Austria. A. Garcı́a-Merino's co-authors include Antonio Sánchez, Elvira Ramil, Claudia F. Lucchinetti, Harry Openshaw, Hans Lassmann, Biagio Azzarelli, O Kolár, Imke Metz, Harry Atkins and Mark S. Freedman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

A. Garcı́a-Merino

18 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Garcı́a-Merino Spain 11 156 155 131 114 105 18 480
Ф. А. Хабиров Russia 7 170 1.1× 73 0.5× 128 1.0× 24 0.2× 108 1.0× 39 452
Dongwei Wang China 10 93 0.6× 225 1.5× 20 0.2× 66 0.6× 188 1.8× 23 692
Silvana Montella Italy 8 129 0.8× 83 0.5× 39 0.3× 14 0.1× 162 1.5× 13 409
Erik Ellwardt Germany 11 274 1.8× 144 0.9× 14 0.1× 85 0.7× 180 1.7× 23 674
Carlos Lorenzana United States 4 140 0.9× 112 0.7× 15 0.1× 50 0.4× 72 0.7× 4 438
Lucía Ayuso‐Peralta Spain 14 174 1.1× 208 1.3× 9 0.1× 55 0.5× 53 0.5× 33 470
Anthony P. Turel United States 8 215 1.4× 115 0.7× 12 0.1× 101 0.9× 73 0.7× 10 444
Anthousa Tsoutsou Greece 12 62 0.4× 281 1.8× 18 0.1× 116 1.0× 121 1.2× 14 610
Qinming Zhou China 12 35 0.2× 241 1.6× 42 0.3× 60 0.5× 21 0.2× 42 411
Anisha Doshi United Kingdom 8 251 1.6× 108 0.7× 9 0.1× 71 0.6× 47 0.4× 31 488

Countries citing papers authored by A. Garcı́a-Merino

Since Specialization
Citations

This map shows the geographic impact of A. Garcı́a-Merino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Garcı́a-Merino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Garcı́a-Merino more than expected).

Fields of papers citing papers by A. Garcı́a-Merino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Garcı́a-Merino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Garcı́a-Merino. The network helps show where A. Garcı́a-Merino may publish in the future.

Co-authorship network of co-authors of A. Garcı́a-Merino

This figure shows the co-authorship network connecting the top 25 collaborators of A. Garcı́a-Merino. A scholar is included among the top collaborators of A. Garcı́a-Merino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Garcı́a-Merino. A. Garcı́a-Merino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
López, Fernando García, A. Garcı́a-Merino, Enrique Alcalde-Cabero, & Jesús de Pedro‐Cuesta. (2022). Incidence and prevalence of multiple sclerosis in Spain: a systematic review. Neurología (English Edition). 39(8). 639–650. 5 indexed citations
2.
López, Fernando García, A. Garcı́a-Merino, Enrique Alcalde-Cabero, & Jesús de Pedro-Cuesta. (2022). Incidencia y prevalencia de la esclerosis múltiple en España. Una revisión sistemática. Neurología. 39(8). 639–650. 6 indexed citations
3.
Marín‐Jiménez, Ignacio, María Dolores Martin‐Arranz, A. Garcı́a-Merino, et al.. (2020). Multidisciplinary Management of the Adverse Effects of Apremilast. Actas Dermo-Sifiliográficas. 112(2). 134–141. 3 indexed citations
4.
Marín‐Jiménez, Ignacio, María Dolores Martin‐Arranz, A. Garcı́a-Merino, et al.. (2020). Manejo de los efectos adversos de apremilast desde un abordaje multidisciplinar. Actas Dermo-Sifiliográficas. 112(2). 134–141. 3 indexed citations
5.
Sánchez, Antonio, et al.. (2014). Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients. Clinical & Experimental Immunology. 179(1). 119–127. 40 indexed citations
6.
Garcı́a-Merino, A., Óscar Fernández, Xavier Montalbán, et al.. (2013). Consensus statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases. SHILAP Revista de lepidopterología. 28(6). 375–378. 9 indexed citations
7.
Garcı́a-Merino, A., Óscar Fernández, Xavier Montalbán, et al.. (2013). Documento del Grupo de Consenso de la Sociedad Española de Neurología sobre el uso de medicamentos en esclerosis múltiple. Neurología. 28(6). 375–378. 10 indexed citations
8.
Sánchez, Antonio & A. Garcı́a-Merino. (2011). Neuroprotective agents: Cannabinoids. Clinical Immunology. 142(1). 57–67. 91 indexed citations
9.
Sánchez, Antonio, José Rodríguez, Elisa Cisneros, et al.. (2009). Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes and Immunity. 10(6). 579–585. 37 indexed citations
10.
Ramil, Elvira, Alfredo Rodríguez Antigüedad, Natalia Gómez‐Lozano, et al.. (2009). The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Multiple Sclerosis Journal. 16(2). 139–146. 21 indexed citations
11.
Metz, Imke, Claudia F. Lucchinetti, Harry Openshaw, et al.. (2007). Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain. 130(5). 1254–1262. 96 indexed citations
12.
Metz, Imke, Claudia F. Lucchinetti, Harry Openshaw, et al.. (2007). Autologous hematopoietic stem cell transplantation: the glass seems to be half full for aggressive, early forms of MS and half empty for advanced MS. Brain. 131(2). e90–e90. 2 indexed citations
13.
Vandenberghe, Rik, A. Garcı́a-Merino, Tatsuya Yamamoto, et al.. (2006). Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology. 68(12). 900–905. 70 indexed citations
14.
Pedro‐Cuesta, Jesús de, J.R. Ara, Carlos Cemillán, et al.. (2004). Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurological Sciences. 25(2). 57–65. 27 indexed citations
15.
Durán-Ruiz, Ma Carmen, et al.. (2003). NFκB and AP-1 DNA binding activity in patients with multiple sclerosis. Journal of Neuroimmunology. 135(1-2). 141–147. 13 indexed citations
16.
17.
Garcı́a-Merino, A., et al.. (1992). IgG anti-ganglioside antibodies and their subclass distribution in two patients with acute and chronic motor neuropathy. Journal of Neuroimmunology. 37(1-2). 141–148. 13 indexed citations
18.
Garcı́a-Merino, A., Mats A. A. Persson, Jan Ernerudh, Juan José Díaz-Gil, & Tomas Olsson. (1986). Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. 49(9). 1066–1070. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ф. А. Хабиров Breakdown of academic impact, for papers by Dongwei Wang Breakdown of academic impact, for papers by Silvana Montella Breakdown of academic impact, for papers by Erik Ellwardt Breakdown of academic impact, for papers by Carlos Lorenzana Breakdown of academic impact, for papers by Lucía Ayuso‐Peralta Breakdown of academic impact, for papers by Anthony P. Turel Breakdown of academic impact, for papers by Anthousa Tsoutsou Breakdown of academic impact, for papers by Qinming Zhou Breakdown of academic impact, for papers by Anisha Doshi
Rankless by CCL
2026